Singh S, Liu Y, Burke M, Rayaprolu V, Stein S, Hasan S
J Struct Biol X. 2025; 11:100123.
PMID: 40046771
PMC: 11880631.
DOI: 10.1016/j.yjsbx.2025.100123.
Tsai Y, Chien Y, Hsu M, Khoo K, Hsu S
Nat Commun. 2025; 16(1):2045.
PMID: 40016196
PMC: 11868633.
DOI: 10.1038/s41467-025-57359-8.
Abiona O, Wang N, Leist S, Schafer A, Cockrell A, Wang L
iScience. 2025; 28(2):111632.
PMID: 39898019
PMC: 11783452.
DOI: 10.1016/j.isci.2024.111632.
Bdeir N, Luddecke T, Maass H, Schmelz S, Rand U, Jacobsen H
Nat Commun. 2025; 16(1):809.
PMID: 39827186
PMC: 11743207.
DOI: 10.1038/s41467-025-55871-5.
Casasnovas J
Subcell Biochem. 2024; 105:533-566.
PMID: 39738957
DOI: 10.1007/978-3-031-65187-8_15.
Conventional Electron Microscopy, Cryogenic Electron Microscopy, and Cryogenic Electron Tomography of Viruses.
Caston J, Luque D
Subcell Biochem. 2024; 105:81-134.
PMID: 39738945
DOI: 10.1007/978-3-031-65187-8_3.
Designed miniproteins potently inhibit and protect against MERS-CoV.
Ragotte R, Tortorici M, Catanzaro N, Addetia A, Coventry B, Froggatt H
bioRxiv. 2024; .
PMID: 39574666
PMC: 11580849.
DOI: 10.1101/2024.11.03.621760.
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
Clark J, Hoxie I, Adelsberg D, Sapse I, Andreata-Santos R, Yong J
Cell Rep. 2024; 43(11):114922.
PMID: 39504245
PMC: 11804229.
DOI: 10.1016/j.celrep.2024.114922.
A human monoclonal antibody neutralizing SARS-CoV-2 Omicron variants containing the L452R mutation.
Stein S, Hansen G, Ssebyatika G, Stroh L, Ochulor O, Herold E
J Virol. 2024; 98(12):e0122324.
PMID: 39494911
PMC: 11650997.
DOI: 10.1128/jvi.01223-24.
Viral entry mechanisms: the role of molecular simulation in unlocking a key step in viral infections.
Valerio M, Buga C, Melo M, Soares C, Lousa D
FEBS Open Bio. 2024; 15(2):269-284.
PMID: 39402013
PMC: 11788750.
DOI: 10.1002/2211-5463.13908.
Cardiovascular adverse effects of antiviral therapies for COVID-19: Evidence and plausible mechanisms.
Chen E, Xi L
Acta Pharmacol Sin. 2024; 46(3):554-564.
PMID: 39251859
PMC: 11845466.
DOI: 10.1038/s41401-024-01382-w.
Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain.
Ma S, Zhang D, Wang Q, Zhu L, Wu X, Ye S
PLoS Pathog. 2024; 20(8):e1012438.
PMID: 39141662
PMC: 11324105.
DOI: 10.1371/journal.ppat.1012438.
Cryo-electron microscopy in the study of virus entry and infection.
Dutta M, Acharya P
Front Mol Biosci. 2024; 11:1429180.
PMID: 39114367
PMC: 11303226.
DOI: 10.3389/fmolb.2024.1429180.
Structural determinants of spike infectivity in bat SARS-like coronaviruses RsSHC014 and WIV1.
Qiao S, Wang X
J Virol. 2024; 98(8):e0034224.
PMID: 39028202
PMC: 11334503.
DOI: 10.1128/jvi.00342-24.
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines.
Lee J, Stewart C, Schafer A, Leaf E, Park Y, Asarnow D
Nat Commun. 2024; 15(1):5496.
PMID: 38944664
PMC: 11214633.
DOI: 10.1038/s41467-024-49656-5.
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.
Li X, Mi Z, Liu Z, Rong P
Front Microbiol. 2024; 15:1334152.
PMID: 38939189
PMC: 11208693.
DOI: 10.3389/fmicb.2024.1334152.
Neutralizing antibodies reveal cryptic vulnerabilities and interdomain crosstalk in the porcine deltacoronavirus spike protein.
Du W, Debski-Antoniak O, Drabek D, van Haperen R, van Dortmondt M, van der Lee J
Nat Commun. 2024; 15(1):5330.
PMID: 38909062
PMC: 11193727.
DOI: 10.1038/s41467-024-49693-0.
Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects.
Nagahawatta D, Liyanage N, Jayawardena T, Jayawardhana H, Jeong S, Kwon H
Mar Life Sci Technol. 2024; 6(2):280-297.
PMID: 38827130
PMC: 11136918.
DOI: 10.1007/s42995-023-00215-9.
Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen.
Ahuja R, Vishwakarma P, Raj S, Kumar V, Khatri R, Lohiya B
Hum Vaccin Immunother. 2024; 20(1):2351664.
PMID: 38757508
PMC: 11110700.
DOI: 10.1080/21645515.2024.2351664.
Structural basis for the recognition of HCoV-HKU1 by human TMPRSS2.
Xia L, Zhang Y, Zhou Q
Cell Res. 2024; 34(7):526-529.
PMID: 38641728
PMC: 11217304.
DOI: 10.1038/s41422-024-00958-9.